Alicia Irurzun-Lafitte joined the previous biopharma fund in 2014 and transitioned to Principal in 2016. Alicia started her career as an analyst in Global Business Development and Licensing in 2010 at Merck KGaA, Darmstadt, Germany in Geneva. In this role she was responsible for search and evaluation efforts across therapeutic areas. Subsequently, she transitioned as a manager for global licensing and business development activities in immunology and fertility. Over the past years, Alicia has been involved on numerous business development and licensing transactions. Alicia holds a Bachelor Honors in Biomedical Science from Edinburgh Napier University and a Master degree in Bio-pharmaceutical Sciences and Science-based-business from Leiden University. Alicia is based in Boston.